$ECL

Vautrinot Suzanne M sold $266K of ECL

Vautrinot Suzanne M sold 1,004 shares of ECOLAB INC. (ECL) at $264.98 ($0.27M total) on 2026-05-27.

Original reporting
SEC EDGAR · Vautrinot Suzanne M
Published May 27, 2026, 8:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ECL
Neutral
medium confidence
Mentioned
$ECL
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ECLNeutralLow
01

Why it matters

Without accompanying company events (earnings, guidance, contracts, litigation, or product/regulatory updates), the disclosure is more relevant for sentiment/positioning than fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone is unlikely to drive a sustained repricing.

03

What to watch

Insider sales can be driven by taxes, diversification, or pre-existing personal liquidity needs; share count is modest relative to typical institutional float.

Relevance 6/10Timing: Same-day disclosure (filed 2026-05-27) may cause minor technical/flow-driven attention.

Background

The article is an SEC Form 4 insider transaction disclosure for Ecolab, reported as an open-market sale by a director.

Company-level read

Ticker impact

$ECLNeutralMedium confidence
Context

Ecolab director Vautrinot Suzanne M sold 1,004 shares in an open-market transaction on 2026-05-27 for ~$266K.

Expected impact

Likely limited near-term impact; any reaction would be small and short-lived unless accompanied by broader company-specific news.

Evidence & confidence

Insider sales can be routine diversification; the filing provides transaction details but no earnings, guidance, or operational change.

Market effects

Minimal; single-director Form 4 sale does not reset sector fundamentals for industrial/cleaning chemicals.

None indicated.

None indicated.

Counterpoint

Because the sale states no pre-arranged 10b5-1 plan, some traders may interpret it as a signal, creating a brief downside bias.

Key entities

  • Ecolab Inc.

    Subject of the insider transaction disclosure; director sold 1,004 shares on 2026-05-27.

  • Vautrinot Suzanne M

    Director who executed the open-market sale; holdings after transaction were 11,651 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ECLMedAI 8/10

Ecolab Inc (ECL) (Q3 2026) Earnings Call Highlights: 7% Organic Sales Growth, 63%

Ecolab Inc (ECL) reported 7% organic sales growth in Q3 2026, with High-Tech segment growing 63%. Challenges include North American restaurant traffic decline, commodity cost inflation, and a 1% growth headwind from the Middle East. CoolIT acquisition is expected to impact EPS. CEO Christophe Beck reaffirmed 2027 margin targets and growth expectations, citing strong demand in High-Tech and Life Sciences.

$ECLMed

Ecolab (ECL) Q3 2026 Earnings Call Transcript

Ecolab (ECL) reported Q3 2026 pro forma sales growth of high single digits and adjusted EPS growth of mid-teens. The company highlighted strong performance in Food & Beverage, Life Sciences, and Global High-Tech, with organic sales growth of 8%, 17%, and 63% respectively. Ecolab also emphasized its One Ecolab model, which integrates water, hygiene, and digital solutions to drive customer value and growth. The company plans to expand field sales and service offerings to accelerate growth further.

$ECLMedAI 8/10

Ecolab Q3 Earnings Call Highlights

Ecolab (ECL) reported Q3 growth in Life Sciences (17%), Ecolab Digital (34%), and Pest Elimination (8%). Global High-Tech saw 63% growth, driven by data-center cooling and water systems. Ecolab expects 2027 organic sales growth at the upper end of its 5%-7% target range and adjusted operating-income margin of 20%. The company is integrating recent acquisitions and reducing leverage.

$ECLHighAI 8/10

Ecolab Q3 2026 slides: organic growth accelerates to 7%, margins expand

Ecolab (ECL) reported Q3 2026 results with 7% organic sales growth, 13% total sales growth, and adjusted EPS of $2.18, slightly above estimates. Revenue was $4.69B, below consensus. Stock rose 1.29% premarket. High-growth segments like Global High-Tech and Life Sciences drove performance. Management expects full-year EPS of $8.10-$8.20 and 2027 margin target of 20%.

$ECLMedAI 8/10

Ecolab Q3 Earnings In-Line With Estimates, Revenues Increase Y/Y

Ecolab reported Q3 2026 adjusted earnings of $2.18 per share, up 5% Y/Y, matching estimates. Revenues rose 13% to $4.69B, beating estimates. Organic sales increased 7%, with strong demand in Global High-Tech and Life Sciences. ECL raised its 2026 adjusted earnings outlook to $8.10-$8.20 per share, citing acquisitions and pricing gains.